Fat Reduction in the Submental Area - a Sequential Treatment Approach With CoolMini and KYBELLA
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Mar 2019
Price : $35 *
At a glance
- Drugs Deoxycholic acid (Primary)
- Indications Subcutaneous fat disorders
- Focus Therapeutic Use
- 11 Mar 2019 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.
- 11 Mar 2019 Planned primary completion date changed from 1 May 2019 to 1 May 2020.
- 22 May 2018 Status changed from recruiting to active, no longer recruiting.